Tender Notice for Silver Sulphadiazine 1 Ointment 20 gm tube,Tab Thyroxine Sodium 75 mcg,Voglibose 0 3mg Tab,Ivermect in CENTRAL DELHI, DELHI
Bid Publish Date
18-Jun-2025, 2:51 pm
Bid End Date
09-Jul-2025, 3:00 pm
Location
Progress
RAQuantity
21372
Category
Silver Sulphadiazine 1 Ointment 20 gm tube
Bid Type
Two Packet Bid
Categories
8
Indian Army invites bids for Silver Sulphadiazine 1 Ointment 20 gm tube, Tab Thyroxine Sodium 75 mcg, Voglibose 0 3mg Tab, Ivermectin 12mg Tab, Ofloxacin Ornidazole Syp, Acarbose 25mg Tab, Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl bottle of 100 ml, Ursodeoxycholic Acid 300mg Tab in CENTRAL DELHI, DELHI. Quantity: 21372. Submission Deadline: 09-07-2025 15: 00: 00. Submit your proposal before the deadline.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Silver Sulphadiazine 1 Ointment 20 gm tube , Tab Thyroxine Sodium 75 mcg , Voglibose 0 3mg Tab , Ivermectin 12mg Tab , Ofloxacin Ornidazole Syp , Acarbose 25mg Tab , Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl bottle of 100 ml , Ursodeoxycholic Acid 300mg Tab
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 5
GeM-Bidding-7981910.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
8 Items Sign in to view GEM price trends Sign in for GEM prices
Silver Sulphadiazine 1 Ointment 20 gm tube
Silver Sulphadiazine 1% Ointment 20 gm tube
Tab Thyroxine Sodium 75 mcg
Tab Thyroxine Sodium 75 mcg
Voglibose 0 3mg Tab
Voglibose 0.3mg Tab
Ivermectin 12mg Tab
Ivermectin 12mg Tab
Ofloxacin Ornidazole Syp
Ofloxacin & Ornidazole Syp
Acarbose 25mg Tab
Acarbose 25mg Tab
Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl bottle of 100 ml
Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl, bottle of 100 ml
Ursodeoxycholic Acid 300mg Tab
Ursodeoxycholic Acid 300mg Tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Silver Sulphadiazine 1 Ointment 20 gm tube | Silver Sulphadiazine 1% Ointment 20 gm tube | 300 | tube | [email protected] | 15 | |
| 2 | Tab Thyroxine Sodium 75 mcg | Tab Thyroxine Sodium 75 mcg | 13,000 | no | [email protected] | 15 | |
| 3 | Voglibose 0 3mg Tab | Voglibose 0.3mg Tab | 3,300 | no | [email protected] | 15 | |
| 4 | Ivermectin 12mg Tab | Ivermectin 12mg Tab | 600 | no | [email protected] | 15 | |
| 5 | Ofloxacin Ornidazole Syp | Ofloxacin & Ornidazole Syp | 72 | bott | [email protected] | 15 | |
| 6 | Acarbose 25mg Tab | Acarbose 25mg Tab | 1,500 | no | [email protected] | 15 | |
| 7 | Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl bottle of 100 ml | Bromhexine Syp 5 ml containing 4 mg of Bromhexine HCl, bottle of 100 ml | 500 | no | [email protected] | 15 | |
| 8 | Ursodeoxycholic Acid 300mg Tab | Ursodeoxycholic Acid 300mg Tab | 2,100 | no | [email protected] | 15 |
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Additional Doc 2 (Requested in ATC)
Additional Doc 4 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Reverse Auction Schedule
Start
17-Sep-2025, 4:00 pm
End
18-Sep-2025, 4:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 08-07-2025 18:05:33 | |
| 2 | ********** Under PMA | - | 02-07-2025 17:12:36 | |
| 3 | ********** Under PMA | - | 03-07-2025 14:08:32 | |
| 4 | ********** Under PMA | - | 09-07-2025 08:03:48 | |
| 5 | ********** Under PMA | - | 07-07-2025 23:13:35 | |
| 6 | ********** Under PMA | - | 05-07-2025 11:46:32 | |
| 7 | ********** Under PMA | - | 09-07-2025 11:04:10 | |
| 8 | ********** Under PMA | - | 05-07-2025 19:06:55 | |
| 9 | ********** Under PMA | - | 03-07-2025 15:02:22 | |
| 10 | ********** Under PMA | - | 23-06-2025 12:32:52 | |
| 11 | ********** Under PMA | - | 08-07-2025 18:49:04 | |
| 12 | ********** Under PMA | - | 07-07-2025 16:43:27 | |
| 13 | ********** Under PMA | - | 09-07-2025 10:36:34 | |
| 14 | ********** Under PMA | - | 04-07-2025 11:33:37 | |
| 15 | ********** Under PMA | - | 08-07-2025 14:40:54 |
Frequently Asked Questions
Key insights about DELHI tender market
What are the eligibility requirements for this tender?
The eligibility requirements include being a registered entity, having relevant certifications in pharmaceutical manufacturing or distribution, and demonstrating experience in supplying similar products to governmental organizations. Bidders must also comply with specific quality standards and regulations set forth by the Department of Military Affairs.
What certifications are required for bidding on this tender?
To qualify for this tender, bidders must possess recognized certifications that signify compliance with industry standards in pharmaceutical manufacturing. These certifications ensure that the products meet safety and efficacy criteria, crucial for military health care provisions.
What is the process for submitting documents for this tender?
Documents must be submitted through the designated online portal in specified formats, such as PDF or DOCX. It is essential to ensure that all submissions follow the guidelines outlined in the tender document to avoid disqualification.
What are the payment terms associated with this tender?
The payment terms will be outlined in the submitted bids and should detail the proposed payment schedules and acceptable modes of payment. Bidders must ensure that their financial proposals are transparent and clear to meet the requirements delineated by the Ministry of Defence.
Are there any special provisions for MSEs or startups?
Yes, this tender provides special provisions for Micro, Small, and Medium Enterprises (MSEs) and startups. Such entities are encouraged to participate and may receive favorable consideration during the evaluation process, thereby promoting inclusiveness in government procurement initiatives.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 5
GeM-Bidding-7981910.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
Buyer uploaded ATC document
ATC
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS